ArticleOncotarget2023
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma.
Silvia Pietrobono et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncotarget2023
Silvia Pietrobono et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.